SRINIVASA KODALI: Open Payments
NPI 1255372058 · LIVONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$335 in 6 payments from 6 companies in 2025. Trend: 2023 $343 · 2024 $441 · 2025 $335
Food & beverage: $335
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $125 |
| ACADIA Pharmaceuticals Inc | 1 | $122 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
Products named: Auvelity, NUPLAZID, REXULTI, COBENFY, FANAPT, Qelbree.
Industry payments across MI — which companies pay providers there.
